Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes

Michel Delforge, Dominik Selleslag, Yves Beguin, Agnès Triffet, Philippe Mineur, Koen Theunissen, Carlos Graux, Fabienne Trullemans, Dominique Boulet, Koen Van Eygen, Lucien Noens, Steven Van Steenweghen, Jan Lemmens, Pascal Pierre, Randal D'hondt, Augustin Ferrant, Dries Deeren, Ann Van De Velde, Wim Wynendaele, Marc AndréRobrecht De Bock, André Efira, Dimitri Breems, Anne Deweweire, Kurt Geldhof, Wim Pluymers, Amanda Harrington, Karen MacDonald, Ivo Abraham, Christophe Ravoet

Research output: Contribution to journalArticlepeer-review

53 Scopus citations

Fingerprint

Dive into the research topics of 'Adequate iron chelation therapy for at least six months improves survival in transfusion-dependent patients with lower risk myelodysplastic syndromes'. Together they form a unique fingerprint.

Medicine & Life Sciences